Detalhe da pesquisa
1.
Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models.
J Immunol
; 209(1): 99-117, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667841
2.
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
Gut
; 64(12): 1961-71, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25429051
3.
Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
Gastroenterology
; 147(1): 119-131.e3, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24657484
4.
The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China.
Arch Virol
; 160(4): 1125-30, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616844
5.
A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.
J Infect Dis
; 208(6): 1008-19, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23776192
6.
IL-7 producing immunotherapy improves ex vivo T cell functions of immunosenescent patients, especially post hip fracture.
Hum Vaccin Immunother
; 19(2): 2232247, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37417353
7.
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.
Gastroenterology
; 141(3): 890-899.e1-4, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699798
8.
A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19.
Front Immunol
; 13: 939899, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045686
9.
Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count.
Hum Vaccin Immunother
; 18(6): 2133914, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315906
10.
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial.
Hum Vaccin Immunother
; 16(2): 388-399, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373537
11.
Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques.
NPJ Vaccines
; 5(1): 39, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32435513
12.
A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model.
Hum Vaccin Immunother
; 14(6): 1417-1422, 2018 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29388874
13.
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
PLoS One
; 13(5): e0196815, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718990
14.
Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
Microbes Infect
; 8(9-10): 2432-41, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16859951
15.
First Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections".
Retrovirology
; 2: 24, 2005 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-15813969
16.
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
Vaccine
; 33(36): 4548-53, 2015 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209840
17.
A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates.
PLoS One
; 10(11): e0143552, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26599077
18.
Development of a hepatitis C virus vaccine.
Clin Liver Dis
; 7(1): 243-59, xi, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12691469
19.
Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models.
Vaccine
; 32(26): 3256-63, 2014 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726690
20.
Hepatitis C vaccine: supply and demand.
Lancet Infect Dis
; 8(12): 739-40, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19022189